We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

6 hedge funds and large institutions have $199K invested in BioCardia, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more funds holding

Funds holding: 5 → 6 (+1)

12% more capital invested

Capital invested by funds: $177K → $199K (+$22K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
G
GenTrust
Florida
+$5.97K

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$8.96K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
1
CAPTRUST Financial Advisors
North Carolina
$175K – – –
Osaic Holdings
2
Osaic Holdings
Arizona
$11K -$8.96K -22,940 -43%
EAM
3
Empery Asset Management
New York
$6K – – –
G
4
GenTrust
Florida
$5K +$5.97K +15,293 New
Bank of America
5
Bank of America
North Carolina
$2K – – –

BCDAW Hedge Fund Activity: Q2 2022 in Review

6 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q2 2022, worth a combined $199K — up 12% from $177K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new BCDAW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was GenTrust, opening a new position worth an estimated $5.97K. The largest seller was Osaic Holdings, cutting an estimated $8.96K.

  • 6 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q2 2022, up from 5 in Q1 2022.
  • Funds reported $199K of BioCardia, Inc. Warrant stock for Q2 2022, up 12% quarter-over-quarter.
  • 1 fund opened new BioCardia, Inc. Warrant positions in Q2 2022 and 0 closed out, a net change of +1 holder.
  • The largest BioCardia, Inc. Warrant buyer in Q2 2022 was GenTrust, an estimated $5.97K added.
  • The largest BioCardia, Inc. Warrant seller in Q2 2022 was Osaic Holdings, an estimated $8.96K sold.

Based on aggregated 13F filings for Q2 2022.